-
1
-
-
0742333328
-
Clinical applications of cell-free fetal DNA from maternal plasma
-
Rijinders R.J., Christiaens G.C., Bossers B., van der Smagt J.J., van der Schoot C.E., and de Haas M. Clinical applications of cell-free fetal DNA from maternal plasma. Obstet. Gynecol. 103 (2004) 157-164
-
(2004)
Obstet. Gynecol.
, vol.103
, pp. 157-164
-
-
Rijinders, R.J.1
Christiaens, G.C.2
Bossers, B.3
van der Smagt, J.J.4
van der Schoot, C.E.5
de Haas, M.6
-
2
-
-
33947306107
-
Circulating nucleic acids in plasma/serum
-
Tsang J.C.H., and Lo Y.M.D. Circulating nucleic acids in plasma/serum. Pathology 39 (2007) 197-207
-
(2007)
Pathology
, vol.39
, pp. 197-207
-
-
Tsang, J.C.H.1
Lo, Y.M.D.2
-
3
-
-
3242670448
-
Circulating methylated DNA
-
Herman J.G. Circulating methylated DNA. Ann. N.Y. Acad. Sci. 1022 (2004) 33-39
-
(2004)
Ann. N.Y. Acad. Sci.
, vol.1022
, pp. 33-39
-
-
Herman, J.G.1
-
4
-
-
0034669126
-
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma
-
Kawakami K., Brabender J., Lord R.A., Groshen S., Greenwald B.D., Krasna M.J., et al. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J. Natl. Cancer Inst. 92 (2000) 1805-1811
-
(2000)
J. Natl. Cancer Inst.
, vol.92
, pp. 1805-1811
-
-
Kawakami, K.1
Brabender, J.2
Lord, R.A.3
Groshen, S.4
Greenwald, B.D.5
Krasna, M.J.6
-
5
-
-
2942755745
-
Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus
-
Januchowski R., Prokop J., and Jagodziński P.P. Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus. J. Appl. Genet. 45 (2004) 237-248
-
(2004)
J. Appl. Genet.
, vol.45
, pp. 237-248
-
-
Januchowski, R.1
Prokop, J.2
Jagodziński, P.P.3
-
6
-
-
12944331281
-
Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation
-
Birch L., English C.A., O'Donoghue K., Barigye O., Fisk N.M., and Keer J.T. Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin. Chem. 51 (2005) 312-320
-
(2005)
Clin. Chem.
, vol.51
, pp. 312-320
-
-
Birch, L.1
English, C.A.2
O'Donoghue, K.3
Barigye, O.4
Fisk, N.M.5
Keer, J.T.6
-
7
-
-
0036177799
-
Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation
-
Lui Y.Y.N., Chik K.W., Chiu R.W.K., Ho C.-Y., Lam C.W.K., and Lo Y.M.D. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin. Chem. 48 (2002) 421-427
-
(2002)
Clin. Chem.
, vol.48
, pp. 421-427
-
-
Lui, Y.Y.N.1
Chik, K.W.2
Chiu, R.W.K.3
Ho, C.-Y.4
Lam, C.W.K.5
Lo, Y.M.D.6
-
8
-
-
40449109999
-
Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21
-
Chim S.S.C., Jin S., Lee T.Y.H., Lun F.M.F., Lee W.S., and Chan L.Y.S. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin. Chem. 54 (2008) 500-511
-
(2008)
Clin. Chem.
, vol.54
, pp. 500-511
-
-
Chim, S.S.C.1
Jin, S.2
Lee, T.Y.H.3
Lun, F.M.F.4
Lee, W.S.5
Chan, L.Y.S.6
-
9
-
-
33845512998
-
Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of non-invasive prenatal diagnosis
-
Chan K.C.A., Ding C., Gerovassili A., Yeung S.W., Chiu R.W.K., Leung T.N., et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of non-invasive prenatal diagnosis. Clin. Chem. 52 (2006) 2211-2218
-
(2006)
Clin. Chem.
, vol.52
, pp. 2211-2218
-
-
Chan, K.C.A.1
Ding, C.2
Gerovassili, A.3
Yeung, S.W.4
Chiu, R.W.K.5
Leung, T.N.6
|